Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (2) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Paediatric investigation plans Remove Paediatric investigation plans filter Referrals Remove Referrals filter

Decision date

From:

To:

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision (2) Apply European Commission final decision filter

Referral type

Article 20 procedures Remove Article 20 procedures filter Article 31 referrals Remove Article 31 referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC Remove PRAC-CHMP-EC filter PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (1) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (1) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (2) Apply Risk minimisation measures filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Conditional approval Remove Conditional approval filter Exceptional circumstances Remove Exceptional circumstances filter Additional monitoring (12) Apply Additional monitoring filter Generic (3) Apply Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

2 results

Remove all filtersRemove all filters

Medicine Referrals Remove Referrals filter Paediatric investigation plans Remove Paediatric investigation plans filter

Referral type Article 20 procedures Remove Article 20 procedures filter Article 31 referrals Remove Article 31 referrals filter

Medicine type Exceptional circumstances Remove Exceptional circumstances filter Conditional approval Remove Conditional approval filter Accelerated assessment Remove Accelerated assessment filter

Referral decision making model PRAC-CHMP-EC Remove PRAC-CHMP-EC filter

Sort by

List item

Referral: Factor VIII

associated names: Iblias, Elocta, Kovaltry, Nuwiq, Obizur, NovoEight, Voncento, ReFacto AF, Kogenate Bayer, Helixate NexGen, Advate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/09/2017, EC decision date: 10/10/2017, Last updated: 05/12/2017
List item

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)

daclatasvir, dasabuvir, sofosbuvir, ledipasvir, simeprevir, ombitasvir, paritaprevir, ritonavir, associated names: Sovaldi, Olysio, Viekirax, Harvoni, Exviera, Daklinza, Article 20 procedures
Status: European Commission final decision, opinion/position date: 15/12/2016, EC decision date: 23/02/2017, Last updated: 09/03/2017

2 results

Referral: Factor VIII

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)